Collegium Pharmaceutical (COLL) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $2.3 million.
- Collegium Pharmaceutical's Other Non-Current Assets fell 4394.63% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 4394.63%. This contributed to the annual value of $8.4 million for FY2024, which is 69923.59% up from last year.
- Collegium Pharmaceutical's Other Non-Current Assets amounted to $2.3 million in Q3 2025, which was down 4394.63% from $3.8 million recorded in Q2 2025.
- Collegium Pharmaceutical's Other Non-Current Assets' 5-year high stood at $8.4 million during Q4 2024, with a 5-year trough of $1.0 million in Q2 2023.
- For the 5-year period, Collegium Pharmaceutical's Other Non-Current Assets averaged around $2.7 million, with its median value being $2.5 million (2021).
- As far as peak fluctuations go, Collegium Pharmaceutical's Other Non-Current Assets tumbled by 5889.28% in 2023, and later surged by 69923.59% in 2024.
- Over the past 5 years, Collegium Pharmaceutical's Other Non-Current Assets (Quarter) stood at $2.5 million in 2021, then changed by 0.0% to $2.5 million in 2022, then plummeted by 58.89% to $1.0 million in 2023, then skyrocketed by 699.24% to $8.4 million in 2024, then plummeted by 72.06% to $2.3 million in 2025.
- Its Other Non-Current Assets stands at $2.3 million for Q3 2025, versus $3.8 million for Q2 2025 and $5.0 million for Q1 2025.